Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

352.950 USD 4.940 1.38%

As of 10:55:11 ET on 01/28/2015.

Snapshot for Biogen Idec Inc (BIIB)

Open: 360.290 Day's Range: 351.400 - 361.380 Volume: 401,966
Previous Close: 357.890 52wk Range: 272.020 - 366.170 1-Yr Rtn: +15.52%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 353.000
  • 1D
  • 1M
  • 1Y
357.890
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) 34.3847
Estimated P/E(12/2014) 26.2738
Relative P/E vs. SPX 1.9124
Earnings Per Share (USD) (ttm) 10.3409
Est. EPS (USD) (12/2014) 13.5340
Est. PEG Ratio 1.2629
Market Cap (M USD) 83,969.78
Shares Outstanding (M) 236.16
30 Day Average Volume 1,823,698
Price/Book (mrq) 7.9921
Price/Sale (ttm) 9.2435
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil